Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Effects of Computer-Assisted Cognitive Rehabilitation Programs With Breast Cancer Survivors

for
Cognitive Impairment, Breast Cancer
Location: Houston TX
Sponsor: Texas Woman's University

Sex: All

Age: 18 - 70+

Code: NCT04027400

Recruiting

The ONE-MIND Study: Evaluating the Efficacy of Online Mindfulness-Based Cancer Recovery During Chemotherapy Treatment

for
Breast Cancer, Colorectal Cancer, Chemotherapy Effect
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT03484000

Recruiting

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

for
Inflammatory Breast Carcinoma, Invasive Breast Carcinoma,
Location: Jacksonville FL, Nassau Bay TX, Houston TX,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00477100

Recruiting

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

for
Breast Neoplasm Female
Location: Madison WI, Iowa City IA
Sponsor: University of Wisconsin, Madison

Sex: Female

Age: 18+

Code: NCT03096418

Recruiting

Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients

for
Breast Cancer, Invasive Breast Cancer, Metastatic Breast Cancer,
Location: Boston MA
Sponsor: Outcomes4Me

Sex: All

Age: 18+

Code: NCT04262518

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

for
HR+/HER2-negative Breast Cancer
Location: Boston MA, Calverton MD, Roanoke VA, Nashville TN,
Sponsor: Totus Medicines

Sex: Female

Age: 18+

Code: NCT05683418

Phase 1, Recruiting

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

for
Breast Carcinoma, Healthy Subject
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: Female

Age: 18+

Code: NCT03897270

Recruiting

Screening Strategies Among High-risk Populations for Anal Cancer

for
Neoplasms, HPV-Related Anal Squamous Cell Carcinoma
Location: Miami FL, Atlanta GA
Sponsor: Lisa Flowers

Sex: All

Age: 30 - 70+

Code: NCT06628570

Recruiting

Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction

for
Breast Cancer, Heart Failure
Location: Ottawa, Toronto, Hamitlon
Sponsor: Population Health Research Institute

Sex: All

Age: 0+

Code: NCT04680442

Phase 2, Recruiting

"Electro Acupuncture in the Treatment and Management of Chemotherapy Induced Peripheral Neuropathy"

for
Breast Cancer
Location: Winnipeg
Sponsor: University of Manitoba

Sex: All

Age: 0+

Code: NCT02821442

Recruiting

BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer

for
Breast Cancer
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT06085742

Phase 2, Recruiting

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

for
Breast Ductal Carcinoma In Situ, COVID-19 Infection,
Location: League City TX, Houston TX, Conroe TX, Sugar Land TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT04169542

Recruiting

Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy

for
Breast Cancer
Location: Voorhees NJ
Sponsor: Virtua Health, Inc.

Sex: Female

Age: 18+

Code: NCT05704842

Recruiting

The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient

for
Breast Cancer
Location: Bryn Mawr PA
Sponsor: Main Line Health

Sex: Female

Age: 18+

Code: NCT01521000

Recruiting

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Los Angeles CA
Sponsor: Biostar Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05681000

Phase 1, Recruiting

LIFE Cancer Survivorship Database for Pediatric Cancer

for
Pediatric Cancer
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles

Sex: All

Age: 0+

Code: NCT01518400

Recruiting

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Fairfax VA, Toronto, Pittsburgh PA, Huntersville NC,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 18+

Code: NCT06480552

Phase 1, Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: New Haven CT, New York NY, Montreal, Wynnewood PA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase 2, Recruiting

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

for
Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT05733000

Phase 2, Recruiting

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

for
Breast Cancer, Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05694559

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial